U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 113

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr6:45649408-54076842
GRCh38:
Chr6:45681671-54212044
See casesPathogenic
(Aug 20, 2012)
no assertion criteria provided
2.
GRCh37:
Chr6:47159515-51292104
GRCh38:
Chr6:47191779-51427306
See casesLikely pathogenic
(Mar 24, 2014)
no assertion criteria provided
3.
GRCh37:
Chr6:50786571
GRCh38:
Chr6:50818858
TFAP2BChar syndrome, not providedBenign
(Sep 10, 2021)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr6:50786607
GRCh38:
Chr6:50818894
TFAP2BM1ICraniosynostosis syndromeLikely pathogenic
(Jul 23, 2019)
no assertion criteria provided
5.
GRCh37:
Chr6:50786652
GRCh38:
Chr6:50818939
TFAP2Bnot providedLikely benign
(May 15, 2018)
criteria provided, single submitter
6.
GRCh37:
Chr6:50791110
GRCh38:
Chr6:50823397
TFAP2Bnot providedLikely benign
(May 15, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr6:50791116
GRCh38:
Chr6:50823403
TFAP2Bnot providedLikely benign
(Mar 30, 2018)
criteria provided, single submitter
8.
GRCh37:
Chr6:50791128
GRCh38:
Chr6:50823415
TFAP2Bnot providedLikely benign
(Jan 3, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr6:50791130
GRCh38:
Chr6:50823417
TFAP2BD31Gnot providedUncertain significance
(Dec 11, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr6:50791135
GRCh38:
Chr6:50823422
TFAP2BV33Inot providedUncertain significance
(Mar 16, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr6:50791154
GRCh38:
Chr6:50823441
TFAP2BR39Pnot providedUncertain significance
(Oct 26, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr6:50791199
GRCh38:
Chr6:50823486
TFAP2BA54Gnot providedUncertain significance
(Nov 6, 2021)
criteria provided, single submitter
13.
GRCh37:
Chr6:50791217
GRCh38:
Chr6:50823504
TFAP2BT60Nnot providedUncertain significance
(Feb 12, 2020)
criteria provided, single submitter
14.
GRCh37:
Chr6:50791237
GRCh38:
Chr6:50823524
TFAP2BP67Snot providedUncertain significance
(Jan 26, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr6:50791256
GRCh38:
Chr6:50823543
TFAP2BP73RChar syndromePathogenic
(Oct 1, 2001)
no assertion criteria provided
16.
GRCh37:
Chr6:50791290
GRCh38:
Chr6:50823577
TFAP2Bnot providedBenign
(Oct 25, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr6:50791310-50791311
GRCh38:
Chr6:50823597-50823598
TFAP2BY93fsnot providedPathogenic
(Jul 1, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr6:50791446
GRCh38:
Chr6:50823733
TFAP2BD136Enot providedUncertain significance
(Sep 2, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr6:50791446
GRCh38:
Chr6:50823733
TFAP2BD136Enot providedUncertain significance
(Jan 12, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr6:50791456
GRCh38:
Chr6:50823743
TFAP2BD140Hnot providedUncertain significance
(Jun 6, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr6:50791472-50791475
GRCh38:
Chr6:50823759-50823762
TFAP2BP147fsPatent ductus arteriosus 2Pathogenic
(Oct 17, 2016)
no assertion criteria provided
22.
GRCh37:
Chr6:50791482
GRCh38:
Chr6:50823769
TFAP2BD148EChar syndromenot providedno assertion provided
23.
GRCh37:
Chr6:50791515
GRCh38:
Chr6:50823802
TFAP2Bnot providedLikely benign
(Aug 20, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr6:50791560
GRCh38:
Chr6:50823847
TFAP2Bnot providedLikely benign
(Aug 16, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr6:50791575
GRCh38:
Chr6:50823862
TFAP2Bnot providedLikely benign
(Sep 1, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr6:50791578
GRCh38:
Chr6:50823865
TFAP2Bnot providedUncertain significance
(Feb 10, 2020)
criteria provided, single submitter
27.
GRCh37:
Chr6:50791584-50791585
GRCh38:
Chr6:50823871-50823872
TFAP2Bnot provided, Char syndromeConflicting interpretations of pathogenicity
(Oct 9, 2022)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr6:50791585-50791592
GRCh38:
Chr6:50823872-50823879
TFAP2Bnot providedBenign
(Oct 27, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr6:50791585-50791588
GRCh38:
Chr6:50823872-50823875
TFAP2Bnot specified, not provided, Char syndrome
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr6:50791588
GRCh38:
Chr6:50823875
TFAP2Bnot specifiedBenigncriteria provided, single submitter
31.
GRCh37:
Chr6:50791592
GRCh38:
Chr6:50823879
TFAP2Bnot providedBenign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr6:50791640
GRCh38:
Chr6:50823927
TFAP2Bnot providedBenign
(May 15, 2021)
criteria provided, single submitter
33.
GRCh37:
Chr6:50796329-50796332
GRCh38:
Chr6:50828616-50828619
TFAP2Bnot providedUncertain significance
(May 23, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr6:50796330
GRCh38:
Chr6:50828617
TFAP2BPatent ductus arteriosus 2Pathogenic
(Oct 17, 2016)
no assertion criteria provided
35.
GRCh37:
Chr6:50796353
GRCh38:
Chr6:50828640
TFAP2BS188Gnot provided, Inborn genetic diseasesConflicting interpretations of pathogenicity
(Dec 15, 2022)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr6:50796393
GRCh38:
Chr6:50828680
TFAP2BInborn genetic diseasesPathogenic
(May 25, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr6:50796394
GRCh38:
Chr6:50828681
TFAP2BCraniosynostosis syndromeLikely pathogenic
(Jul 23, 2019)
no assertion criteria provided
38.
GRCh37:
Chr6:50796397
GRCh38:
Chr6:50828684
TFAP2BPatent ductus arteriosus 2, Char syndromePathogenic
(Feb 22, 2005)
no assertion criteria provided
39.
GRCh37:
Chr6:50796407
GRCh38:
Chr6:50828694
TFAP2Bnot providedLikely benign
(Jun 14, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr6:50796634
GRCh38:
Chr6:50828921
TFAP2Bnot providedBenign
(Nov 12, 2018)
criteria provided, single submitter
41.
GRCh38:
Chr6:50836056-50836065
TFAP2BChronic intestinal pseudoobstructionPathogenic
(May 12, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr6:50803785
GRCh38:
Chr6:50836072
TFAP2BP205Snot providedUncertain significance
(Oct 30, 2020)
criteria provided, single submitter
43.
GRCh37:
Chr6:50803821
GRCh38:
Chr6:50836108
TFAP2BG217fsChar syndromePathogenic
(Nov 14, 2017)
criteria provided, single submitter
44.
GRCh37:
Chr6:50803842
GRCh38:
Chr6:50836129
TFAP2BV224IInborn genetic diseases, not providedUncertain significance
(Jul 13, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr6:50803863
GRCh38:
Chr6:50836150
TFAP2BC231Rnot providedUncertain significance
(Jul 26, 2019)
criteria provided, single submitter
46.
GRCh37:
Chr6:50803878
GRCh38:
Chr6:50836165
TFAP2BR236SChar syndromePathogenic
(Oct 1, 2001)
no assertion criteria provided
47.
GRCh37:
Chr6:50803878
GRCh38:
Chr6:50836165
TFAP2BR236CChar syndromePathogenic
(Oct 1, 2001)
no assertion criteria provided
48.
GRCh37:
Chr6:50803879
GRCh38:
Chr6:50836166
TFAP2BR236HChar syndromeLikely pathogenic
(Oct 22, 2021)
no assertion criteria provided
49.
GRCh37:
Chr6:50803892
GRCh38:
Chr6:50836179
TFAP2Bnot providedLikely benign
(Apr 26, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr6:50803944
GRCh38:
Chr6:50836231
TFAP2BS258AChar syndromenot providedno assertion provided
51.
GRCh37:
Chr6:50803973
GRCh38:
Chr6:50836260
TFAP2Bnot providedLikely benign
(Oct 20, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr6:50804008-50804013
GRCh38:
Chr6:50836295-50836300
TFAP2Bnot providedLikely benign
(Sep 28, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr6:50805687
GRCh38:
Chr6:50837974
TFAP2BChar syndromenot providedno assertion provided
54.
GRCh37:
Chr6:50805690
GRCh38:
Chr6:50837977
TFAP2BA275DChar syndromePathogenic
(Nov 20, 2019)
criteria provided, single submitter
55.
GRCh37:
Chr6:50805693
GRCh38:
Chr6:50837980
TFAP2BK276RCraniosynostosis syndromeLikely pathogenic
(Jul 23, 2019)
no assertion criteria provided
56.
GRCh37:
Chr6:50805696
GRCh38:
Chr6:50837983
TFAP2BS277WChar syndrome, Bifid nasal tip, Upslanted palpebral fissure,
Hypertelorism, Clinodactyly of the 5th finger, Opacification of the corneal stroma
Uncertain significance
(Nov 19, 2021)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr6:50805720
GRCh38:
Chr6:50838007
TFAP2BR285Qnot provided, Char syndromePathogenic/Likely pathogenic
(Dec 27, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr6:50805727
GRCh38:
Chr6:50838014
TFAP2BR287Snot specifiedUncertain significance
(May 16, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr6:50805764
GRCh38:
Chr6:50838051
TFAP2BR300CChar syndromePathogenic
(May 1, 2000)
no assertion criteria provided
60.
GRCh37:
Chr6:50805783
GRCh38:
Chr6:50838070
TFAP2BT306MChar syndromeUncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr6:50805942
GRCh38:
Chr6:50838229
TFAP2Bnot providedBenign
(Nov 12, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr6:50807897
GRCh38:
Chr6:50840184
TFAP2BF323LInborn genetic diseasesUncertain significance
(Nov 8, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr6:50807899
GRCh38:
Chr6:50840186
TFAP2BG324Anot providedUncertain significance
(Mar 30, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr6:50807910
GRCh38:
Chr6:50840197
TFAP2BE328QInborn genetic diseasesUncertain significance
(Apr 28, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr6:50807925
GRCh38:
Chr6:50840212
TFAP2BA333Snot providedLikely benign
(Oct 11, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr6:50807933
GRCh38:
Chr6:50840220
TFAP2Bnot providedLikely benign
(Jul 16, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr6:50807934
GRCh38:
Chr6:50840221
TFAP2BV336Inot providedBenign
(Jan 17, 2020)
criteria provided, single submitter
68.
GRCh37:
Chr6:50807966
GRCh38:
Chr6:50840253
TFAP2BD346Enot providedUncertain significance
(Mar 29, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr6:50810497
GRCh38:
Chr6:50842784
TFAP2Bnot providedBenign
(Nov 12, 2018)
criteria provided, single submitter
70.
GRCh37:
Chr6:50810826
GRCh38:
Chr6:50843113
TFAP2Bnot providedBenign
(Aug 12, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr6:50810827
GRCh38:
Chr6:50843114
TFAP2BD369HChar syndromeUncertain significance
(Feb 13, 2019)
criteria provided, single submitter
72.
GRCh37:
Chr6:50810838
GRCh38:
Chr6:50843125
TFAP2Bnot providedLikely benign
(Nov 14, 2017)
criteria provided, single submitter
73.
GRCh37:
Chr6:50810866
GRCh38:
Chr6:50843153
TFAP2BR382*Craniosynostosis syndromeLikely pathogenic
(Jul 23, 2019)
no assertion criteria provided
74.
GRCh37:
Chr6:50810881
GRCh38:
Chr6:50843168
TFAP2Bnot providedBenign
(Aug 28, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr6:50810915
GRCh38:
Chr6:50843202
TFAP2BF398Snot providedUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr6:50810964
GRCh38:
Chr6:50843251
TFAP2Bnot providedLikely benign
(Jul 30, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr6:50810967
GRCh38:
Chr6:50843254
TFAP2Bnot providedLikely benign
(Jul 19, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr6:50811011
GRCh38:
Chr6:50843298
TFAP2BK430Mnot providedUncertain significance
(Dec 9, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr6:50811024
GRCh38:
Chr6:50843311
TFAP2BN434KChar syndrome, Patent ductus arteriosus 2Uncertain significance
(Jun 23, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr6:50811026
GRCh38:
Chr6:50843313
TFAP2BN435Tnot provided, Inborn genetic diseasesConflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr6:50811039
GRCh38:
Chr6:50843326
TFAP2Bnot providedLikely benign
(Feb 18, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr6:50811115
GRCh38:
Chr6:50843402
TFAP2Bnot specified, not providedBenign
(May 5, 2021)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr6:50811120-50811122
GRCh38:
Chr6:50843407-50843409
TFAP2BChar syndromeLikely benign
(Jun 14, 2016)
criteria provided, single submitter
84.
GRCh37:
Chr6:50811238
GRCh38:
Chr6:50843525
TFAP2Bnot providedBenign
(May 19, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr6:50811238-50811239
GRCh38:
Chr6:50843525-50843526
TFAP2BChar syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
86.
GRCh37:
Chr6:50811241
GRCh38:
Chr6:50843528
TFAP2Bnot providedBenign
(May 15, 2021)
criteria provided, single submitter
87.
GRCh37:
Chr6:50811283
GRCh38:
Chr6:50843570
TFAP2Bnot providedBenign
(May 19, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr6:50812004-50812005
GRCh38:
Chr6:50844291-50844292
TFAP2BChar syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
89.
GRCh37:
Chr6:50812004
GRCh38:
Chr6:50844291
TFAP2Bnot provided, Char syndromeConflicting interpretations of pathogenicity
(May 17, 2021)
criteria provided, conflicting interpretations
90.
GRCh37:
Chr6:50812015
GRCh38:
Chr6:50844302
TFAP2Bnot providedBenign
(May 15, 2021)
criteria provided, single submitter
91.
GRCh37:
Chr6:50812015-50812016
GRCh38:
Chr6:50844302-50844303
TFAP2BChar syndrome, not providedConflicting interpretations of pathogenicity
(May 15, 2021)
criteria provided, conflicting interpretations
92.
GRCh37:
Chr6:50812015-50812016
GRCh38:
Chr6:50844302-50844303
TFAP2BChar syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
93.
GRCh37:
Chr6:50812015-50812019
GRCh38:
Chr6:50844302-50844306
TFAP2BChar syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
94.
GRCh37:
Chr6:50812016-50812019
GRCh38:
Chr6:50844303-50844306
TFAP2BChar syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
95.
GRCh37:
Chr6:50812016-50812017
GRCh38:
Chr6:50844303-50844304
TFAP2BChar syndrome, not providedConflicting interpretations of pathogenicity
(May 16, 2021)
criteria provided, conflicting interpretations
96.
GRCh37:
Chr6:50812017
GRCh38:
Chr6:50844304
TFAP2Bnot providedBenign
(May 15, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr6:50812017-50812021
GRCh38:
Chr6:50844304-50844308
TFAP2BChar syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
98.
GRCh37:
Chr6:50812530
GRCh38:
Chr6:50844817
TFAP2BChar syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
99.
GRCh37:
Chr6:50812748
GRCh38:
Chr6:50845035
TFAP2BChar syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
100.
GRCh37:
Chr6:50813038-50813039
GRCh38:
Chr6:50845325-50845326
TFAP2BChar syndromeLikely benign
(Jun 14, 2016)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination